DexComDXCM +1.18%90 FCF Yield % is 5.31 as of Jun. 24, 2026, which is 865% above its 10-year median of 0.55. GuruFocus rates DXCM with a GF Score™ of 90/100 and a GF Value™ of $103.50 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, DexCom ranks better than 82.46% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, DexCom's Trailing 12-Month Free Cash Flow is $1,429 Mil, and Market Cap is $26,915 Mil. Therefore, DexCom's FCF Yield % for today is 5.31%.
The historical rank and industry rank for DexCom's FCF Yield % or its related term are showing as below:
DXCM'
s FCF Yield % Range Over the Past 10 Years
Min: -0.41 Med: 0.55 Max: 5.99
Current: 5.31
During the past 13 years, the highest FCF Yield % of DexCom was 5.99%. The lowest was -0.41%. And the median was 0.55%.
DXCM's FCF Yield % is ranked better than 82.46% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs DXCM: 5.31
DexCom's FCF Margin % for the quarter that ended in Mar. 2026 was 37.67%.
DexCom FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
DexCom FCF Yield % Related Terms
DexCom FCF Yield % Historical Data
* Premium members only.
The historical data trend for DexCom's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, DexCom's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DexCom FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, DexCom's FCF Yield % distribution charts can be found below:
* The bar in red indicates where DexCom's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexCom (DXCM) has a FCF Yield % of 5.31 as of Jun. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DexCom and its competitors. This is 865% above median its historical median of 0.55. According to the industry distribution chart, DexCom ranks #150 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 17.5%.
Is DexCom's FCF Yield % too high?
DexCom's current FCF Yield % of 5.31 is 865% above median its 10-year median of 0.55. Based on the distribution chart, DexCom ranks #150 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, DexCom has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DexCom's FCF Yield % compare to GEHC and STE?
According to the Medical Devices & Instruments industry distribution chart, DexCom ranks #150 out of 855 companies for FCF Yield %. This places DexCom in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DexCom and its competitors. DexCom's current FCF Yield % is 5.31, which is 865% above median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
Based on GuruFocus' analysis, DexCom (DXCM) is currently considered Significantly Undervalued. The stock's GF Value™ is $103.50, compared to a current price of $69.75 — trading 32.6% below its estimated fair value. The current FCF Yield % is 5.31, which is 865% above median its 10-year median of 0.55. DexCom's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For DexCom (DXCM), the current FCF Yield % is 5.31 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DexCom (DXCM) Overvalued in 2026?
Based on GuruFocus' analysis, DexCom stock appears to be undervalued.
The current stock price of $69.75 is trading 32.6% below its estimated GF Value™ of $103.50.
GuruFocus considers DexCom to be Significantly Undervalued.
Key valuation signals for DXCM:
FCF Yield %: 5.31 (865% above median its 10-year median of 0.55)
GF Value™: $103.50 vs. price of $69.75 (32.6% below fair value)
No single metric tells the full story. See the DXCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
90GF Score
Get the complete analysis for DXCM
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DXCM has been successfully added to your 
